Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-14T06:28:46.198Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (November 2008)

Published online by Cambridge University Press:  01 July 2009

R. Sutherland
R. Sutherland
Affiliation:
Cancer Research ProgramGarvan Institute of Medical ResearchDarlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 12 , Issue 7 , July 2009 , e12
Copyright
Copyright © Cambridge University Press 2009

References

1.Alcaraz, J, Xu, R, Mori, H, Nelson, CM, Mroue, R, Spencer, VA, Brownfield, D, Radisky, DC, Bustamante, C, Bissell, MJ. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J 2008; 27: 2829–2838.CrossRefGoogle ScholarPubMed
2.Behmoaram, E, Bijian, K, Jie, S, Xu, YJ, Darnel, A, Bismar, TA, Alaoui-Jamali, MA. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Am J Pathol 2008; 173: 1540–1550.CrossRefGoogle ScholarPubMed
3.Brinton, LA, Richesson, D, Leitzmann, MF, Gierach, GL, Schatzkin, A, Mouw, T, Hollenbeck, AR, Lacey, JV. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 2008; 17: 3150–3160.CrossRefGoogle ScholarPubMed
4.Chlebowski, RT, Johnson, KC, Kooperberg, C, Pettinger, M, Wactawski-Wende, J, Rohan, T, Rossouw, J, Lane, D, O’Sullivan, MJ, Yasmeen, S, Hiatt, RA, Shikany, JM, Vitolins, M, Khandekar, J, Hubbell, FA. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008; 100: 1581–1591.CrossRefGoogle ScholarPubMed
5.Harbeck, N, Nimmrich, I, Hartmann, A, Ross, JS, Cufer, T, Gruetzmann, R, Kristiansen, G, Paradiso, A, Hartmann, O, Margossian, A, Martens, J, Schwope, I, Lukas, A, Mueller, V, Milde-Langosch, K, Nahrig, J, Foekens, J, Maier, S, Schmitt, M, Lesche, R. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol 2008; 26: 5036–5042.CrossRefGoogle ScholarPubMed
6.Helczynska, K, Larsson, AM, Mengelbier, LH, Bridges, E, Fredlund, E, Borgquist, S, Landberg, G, Pahlman, S, Jirstrom, K. Hypoxia-Inducible Factor-2 α correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 2008; 68: 9212–9220.CrossRefGoogle ScholarPubMed
7.Johansson, H, Gandini, S, Guerrieri-Gonzaga, A, Iodice, S, Ruscica, M, Bonanni, B, Gulisano, M, Magni, P, Formelli, F, Decensi, A. Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. Cancer Res 2008; 68: 9512–9518.CrossRefGoogle ScholarPubMed
8.Kim, H, Chung, H, Kim, HJ, Lee, JY, Oh, MY, Kim, Y, Kong, G. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κ B in MCF-7 breast cancer cells. Breast Cancer Res Treat 2008; 112: 287–296.CrossRefGoogle ScholarPubMed
9.Kruschinski, A, Moosmann, A, Poschke, I, Norell, H, Chmielewski, M, Seliger, B, Kiessling, R, Blankenstein, T, Abken, H, Charo, J. Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas. Proc Natl Acad Sci USA 2008; 105: 17481–17486.CrossRefGoogle ScholarPubMed
10.Lee, E, Ma, H, McKean-Cowdin, R, Van Den Berg, D, Bernstein, L, Henderson, BE, Ursin, G. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Cancer Epidemiol Biomarkers Prev 2008; 17: 3170–3178.CrossRefGoogle ScholarPubMed
11.Mathes, RW, Malone, KE, Daling, JR, Davis, S, Lucas, SM, Porter, PL, Li, CI. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 3116–3122.CrossRefGoogle ScholarPubMed
12.Nikolsky, Y, Sviridov, E, Yao, J, Dosymbekov, D, Ustyansky, V, Kaznacheev, V, Dezso, Z, Mulvey, L, Macconaill, LE, Winckler, W, Serebryiskaya, T, Nikolskaya, T, Polyak, K. Genome-wide functional synergy between amplified and mutated genes in human breast cancer. Cancer Res 2008; 68: 9532–9540.CrossRefGoogle ScholarPubMed
13.Pankratz, VS, Hartmann, LC, Degnim, AC, Vierkant, RA, Ghosh, K, Vachon, CM, Frost, MH, Maloney, SD, Reynolds, C, Boughey, JC. Assessment of the accuracy of the Gail Model in women with atypical hyperplasia. J Clin Oncol 2008; 26: 5374–5379.CrossRefGoogle ScholarPubMed
14.Phillips, GDL, Li, GM, Dugger, DL, Crocker, LM, Parsons, KL, Mai, E, Blattler, WA, Lambert, JM, Chari, RVJ, Lutz, RJ, Wong, WLT, Jacobson, FS, Koeppen, H, Schwall, RH, Kenkare-Mitra, SR, Spencer, SD, Sliwkowski, MX. Targeting HER2-positive breast cancer with Trastuzumab-DM1, an antibody–cytotoxic drug conjugate. Cancer Res 2008; 68: 9280–9290.CrossRefGoogle Scholar
15.Plo, I, Laulier, C, Gauthier, L, Lebrun, F, Calvo, F, Lopez, BS. AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51. Cancer Res 2008; 68: 9404–9412.CrossRefGoogle ScholarPubMed
16.Provenzano, PP, Inman, DR, Eliceiri, KW, Beggs, HE, Keely, PJ. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol 2008; 173: 1551–1565.CrossRefGoogle Scholar
17.Rottenberg, S, Jaspers, JE, Kersbergen, A, van der Burg, E, Nygren, AOH, Zander, SAL, Derksen, PWB, de Bruin, M, Zevenhoven, J, Lau, A, Boulter, R, Cranston, A, O’Connor, MJ, Martin, NMB, Borst, P, Jonkers, J. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci USA 2008; 105: 17079–17084.CrossRefGoogle Scholar
18.Saunus, JM, French, JD, Edwards, SL, Beveridge, DJ, Hatchell, EC, Wagner, SA, Stein, SR, Davidson, A, Simpson, KJ, Francis, GD, Leedman, PJ, Brown, MA. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR. Cancer Res 2008; 68: 9469–9478.CrossRefGoogle ScholarPubMed
19.Schwabedissen, H, Tirona, RG, Yip, CS, Ho, RH, Kim, RB. Interplay between the nuclear receptor Pregnane X receptor and the uptake transporter organic anion transporter Polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 2008; 68: 9338–9347.CrossRefGoogle Scholar
20.Sieri, S, Krogh, V, Ferrari, P, Berrino, F, Pala, V, Thiebaut, ACM, Tjonneland, A, Olsen, A, Overvad, K, Jakobsen, MU, Clavel-Chapelon, F, Chajes, V, Boutron-Ruault, MC, Kaaks, R, Linseisen, J, Boeing, H, Nothlings, U, Trichopoulou, A, Naska, A, Lagiou, P, Panico, S, Palli, D, Vineis, P, Tumino, R, Lund, E, Kumle, M, Skeie, G, Gonzalez, CA, Ardanaz, E, Amiano, P, Tormo, MJ, Martinez-Garcia, C, Quiros, JR, Berglund, G, Gullberg, B, Hallmans, G, Lenner, P, Bueno-de-Mesquita, HB, van Duijnhoven, FJB, Peeters, PHM, van Gils, CH, Key, TJ, Crowe, FL, Bingham, S, Khaw, KT, Rinaldi, S, Slimani, N, Jenab, M, Norat, T, Riboli, E. Dietary fat and breast cancer risk in the European prospective investigation into cancer and nutrition. Am J Clin Nutr 2008; 88: 1304–1312.CrossRefGoogle ScholarPubMed
21.Sonestedt, E, Borgquist, S, Ericson, U, Gullberg, B, Olsson, H, Adlercreutz, H, Landberg, G, Wirfalt, E. Enterolactone is differently associated with estrogen receptor β-negative and -positive breast cancer in a Swedish nested case–control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 3241–3251.CrossRefGoogle Scholar
22.Su, G, Blaine, SA, Qiao, DH, Friedl, A. Membrane type 1 matrix metalloproteinase-mediated stromal Syndecan-1 shedding stimulates breast carcinoma cell proliferation. Cancer Res 2008; 68: 9558–9565.CrossRefGoogle ScholarPubMed
23.Van der Auwera, I, Van Laere, SJ, Van den Bosch, SM, Van den Eynden, GG, Trinh, BX, van Dam, PA, Colpaert, CG, van Engeland, M, Van Marck, EA, Vermeulen, PB, Dirix, LY. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer 2008; 99: 1735–1742.CrossRefGoogle ScholarPubMed
24.Van Laere, S, Beissbarth, T, Van der Auwera, I, Van den Eynden, G, Trinh, XB, Elst, H, Van Hummelen, P, van Dam, P, Van Marck, E, Vermeulen, P, Dirix, L. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer. Clin Cancer Res 2008; 14: 7452–7460.CrossRefGoogle ScholarPubMed
25.Walker, LC, Waddell, N, Ten Haaf, A, Grimmond, S, Spurdle, AB. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2008; 112: 229–236.CrossRefGoogle ScholarPubMed
26.Wayne, S, Neuhouser, ML, Ulrich, CM, Koprowski, C, Wiggins, C, Baumgartner, KB, Bernstein, L, Baumgartner, RN, Gilliland, F, McTiernan, A, Ballard-Barbash, R. Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2008; 17: 3224–3232.CrossRefGoogle ScholarPubMed
27.Wolf, I, Levanon-Cohen, S, Bose, S, Ligumsky, H, Sredni, B, Kanety, H, Kuro-o, M, Karlan, B, Kaufman, B, Koeffler, HP, Rubinek, T. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 2008; 27: 7094–7105.CrossRefGoogle Scholar
28.Zhang, HJ, Liu, G, Dziubinski, M, Yang, ZQ, Ethier, SP, Wu, GJ. Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells. Breast Cancer Res Treat 2008; 112: 217–227.CrossRefGoogle ScholarPubMed
29.Zhao, JJ, Lin, JH, Yang, H, Kong, W, He, LL, Ma, X, Coppola, D, Cheng, JQ. MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008; 283: 31079–31086.CrossRefGoogle ScholarPubMed